ATE390928T1 - Zusammensetzungen zur behandlung von hauterkrankungen - Google Patents

Zusammensetzungen zur behandlung von hauterkrankungen

Info

Publication number: ATE390928T1
Authority: AT; Austria
Prior art keywords: compositions; skin diseases; treating skin; present; skin disorders
Prior art date: 2002-02-15

Application number

AT03739405T

Other languages

English (en)

Inventor

Patricia Conway

Paul Collier

Original Assignee

Probiomics Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-02-15

Filing date

2003-02-17

Publication date

2008-04-15

2003-02-17 Application filed by Probiomics Ltd filed Critical Probiomics Ltd

2008-04-15 Application granted granted Critical

2008-04-15 Publication of ATE390928T1 publication Critical patent/ATE390928T1/de

Classifications

- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
- A23L2/02—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof containing fruit or vegetable juices
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
- A23L2/38—Other non-alcoholic beverages
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
- A23L2/52—Adding ingredients
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
- A23L2/52—Adding ingredients
- A23L2/56—Flavouring or bittering agents
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
- A23L2/52—Adding ingredients
- A23L2/60—Sweeteners
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/143—Fermentum

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Nutrition Science (AREA)
Food Science & Technology (AREA)
Polymers & Plastics (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Microbiology (AREA)
Mycology (AREA)
Bioinformatics & Cheminformatics (AREA)
Dermatology (AREA)
Epidemiology (AREA)
Molecular Biology (AREA)
Oncology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Communicable Diseases (AREA)
Toxicology (AREA)
Pulmonology (AREA)
Immunology (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicinal Preparation (AREA)
Cosmetics (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AT03739405T 2002-02-15 2003-02-17 Zusammensetzungen zur behandlung von hauterkrankungen ATE390928T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
AUPS0571A AUPS057102A0 (en)	2002-02-15	2002-02-15	Compositions and methods for treatment of skin disorders

Publications (1)

Publication Number	Publication Date
ATE390928T1 true ATE390928T1 (de)	2008-04-15

Family

ID=3834171

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT03739405T ATE390928T1 (de)	2002-02-15	2003-02-17	Zusammensetzungen zur behandlung von hauterkrankungen

Country Status (9)

Country	Link
US (2)	US20050201996A1 (de)
EP (1)	EP1482959B1 (de)
JP (1)	JP2005525339A (de)
KR (1)	KR20040096576A (de)
CN (1)	CN1642563A (de)
AT (1)	ATE390928T1 (de)
AU (1)	AUPS057102A0 (de)
DE (1)	DE60320095D1 (de)
WO (1)	WO2003068250A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AUPS057102A0 (en) *	2002-02-15	2002-03-07	Vri Biomedical Ltd	Compositions and methods for treatment of skin disorders
WO2005030230A1 (en) *	2003-09-30	2005-04-07	Probiomics Limited	Compositions and methods for treatment or prevention of psoriasis and related disorders
AU2005227234B2 (en)	2004-03-04	2008-09-04	E-L Management Corporation	Skin treatment method with lactobacillus extract
JP4823503B2 (ja) *	2004-10-14	2011-11-24	ジェンモントバイオテックインコーポレイテッド	Ｌａｃｔｏｂａｃｉｌｌｕｓｆｅｒｍｅｎｔｕｍの新規微生物株ＧＭ−０９０、およびＩＦＮ−γ分泌の刺激および／またはアレルギーの処置のためのその使用。
US20060269508A1 (en) *	2005-03-29	2006-11-30	Trejo Amy V	Means for regulating the cosmetic appearance and/or health of human keratinous tissue
JP2006273783A (ja) *	2005-03-30	2006-10-12	Musashino Seiyaku Kk	掻痒の予防及び／又は治療用組成物
JP4800015B2 (ja) *	2005-11-22	2011-10-26	株式会社カロッツェリアジャパン	皮膚炎発症抑制のための微生物培養物並びにそれらを用いた製品
BRPI0719431A2 (pt) *	2006-12-01	2013-12-03	Organobalance Gmbh	Composição, kit, uso de uma combinação de microorganismo, e, método para a produção da composição ou do kit.
JP2010530000A (ja) *	2007-06-13	2010-09-02	ザイモジェネティクス，インコーポレイティド	アタシセプトなどのＴＡＣＩ−Ｉｇ融合タンパク質を用いた自己免疫疾患を治療するための投薬法
US20100273239A1 (en) *	2007-06-27	2010-10-28	Benedicte Flambard	Lactobacillus helveticus bacterium composition for treatment of atopic dermatitis
FR2920305B1 (fr)	2007-09-04	2010-07-30	Oreal	Utilisation d'un lysat de bifidobacterium species pour le traitement de peaux sensibles.
FR2920304B1 (fr)	2007-09-04	2010-06-25	Oreal	Utilisation cosmetique de lysat bifidobacterium species pour le traitement de la secheresse.
FR2938437B1 (fr) *	2008-11-19	2020-03-27	Société des Produits Nestlé S.A.	Utilisation cosmetique de microorganisme pour le traitement des peaux grasses
FR2942719B1 (fr)	2009-03-04	2011-08-19	Oreal	Utilisation de microorganismes probiotiques pour limiter les irritations cutanees
US20100260695A1 (en) *	2009-04-09	2010-10-14	Mary Kay Inc.	Combination of plant extracts to improve skin tone
WO2011003062A2 (en) *	2009-07-03	2011-01-06	James Madison University	Probiotic compositions and processes thereof
EP2332557A1 (de) *	2009-12-08	2011-06-15	Campina Nederland Holding B.V.	Probiotische Milchsäurebakterien
CN102838660B (zh) *	2011-06-23	2016-11-02	上海市第一人民医院	一种抑制炎症免疫反应的小肽及其应用
EP3324986B1 (de) *	2015-07-20	2021-11-24	Quorum Innovations, LLC	Materialien und verfahren zur verbesserung von immunreaktionen sowie der haut- und/oder schleimhautbarrierefunktion
US11229806B2 (en)	2017-05-08	2022-01-25	L'oreal	Cold atmospheric plasma treatment with chemical or organic compounds to modify the keratinous substrate microbiota
JP7345382B2 (ja) *	2018-12-28	2023-09-15	東京エレクトロン株式会社	プラズマ処理装置及び制御方法
AU2020271885A1 (en)	2019-04-09	2021-11-25	Dermbiont, Inc.	Compositions and methods for improving skin health and for the treatment and prevention of diseases, disorders and conditions associated with pathogenic microbes
US20220378025A1 (en) *	2019-11-11	2022-12-01	Biocytogen Pharmaceuticals (Beijing) Co., Ltd.	Genetically modified non-human animal with human or chimeric genes
CN113832050B (zh) *	2021-08-13	2022-10-21	广东省科学院微生物研究所(广东省微生物分析检测中心)	一株高效合成烟酰胺、抗光老化的发酵乳杆菌xjc60及其应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6241983B1 (en) *	1994-10-28	2001-06-05	Metagenics, Inc.	Bacteria-and fiber-containing composition for human gastrointestinal health
JPH092959A (ja) *	1995-06-16	1997-01-07	Yakult Honsha Co Ltd	ＩｇＥ抗体産生抑制剤および抗アレルギー剤
US6506389B2 (en) *	1995-10-20	2003-01-14	Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek (Tno)	Adherence factors of non pathogenic microorganisms and applications thereof for screening microorganisms for specific probiotic properties; novel pharmaceutical compositions and food additives comprising such microorganisms and adherence factors
JPH09263539A (ja) *	1996-03-29	1997-10-07	Nichinichi Seiyaku Kk	抗真菌作用を有する皮膚疾患治療剤
JP2944662B1 (ja) *	1998-09-24	1999-09-06	ニチニチ製薬株式会社	酒さ治療剤
AU4905400A (en) *	1999-05-25	2000-12-12	Andrew W. Bruce	Lactobacillus compositions and methods for preventing wound infections and biofilm formation on implantable surgical devices
DE60110380T3 (de) *	2000-01-18	2010-05-20	The Procter & Gamble Company, Cincinnati	Artikel die milchsäureproduzierende mikroorganismen enthalten
AU7675601A (en) *	2000-12-08	2002-06-18	Pl Bio Co Ltd	Lactic acid bacteria with inhibiting activities on (helicobacter pylori)
AUPS057102A0 (en) *	2002-02-15	2002-03-07	Vri Biomedical Ltd	Compositions and methods for treatment of skin disorders
AU2002951270A0 (en) *	2002-09-06	2002-09-19	Vri Biomedical Ltd	Probiotic Bacterium and Methods of Use

2002
- 2002-02-15 AU AUPS0571A patent/AUPS057102A0/en not_active Abandoned
2003
- 2003-02-17 CN CNA038060027A patent/CN1642563A/zh active Pending
- 2003-02-17 AT AT03739405T patent/ATE390928T1/de not_active IP Right Cessation
- 2003-02-17 EP EP03739405A patent/EP1482959B1/de not_active Expired - Lifetime
- 2003-02-17 JP JP2003567430A patent/JP2005525339A/ja not_active Withdrawn
- 2003-02-17 DE DE60320095T patent/DE60320095D1/de not_active Expired - Lifetime
- 2003-02-17 WO PCT/AU2003/000200 patent/WO2003068250A1/en active IP Right Grant
- 2003-02-17 KR KR20047012690A patent/KR20040096576A/ko not_active Application Discontinuation
- 2003-02-17 US US10/504,697 patent/US20050201996A1/en not_active Abandoned
2009
- 2009-03-03 US US12/396,649 patent/US20100028313A1/en not_active Abandoned

Also Published As

Publication number	Publication date
KR20040096576A (ko)	2004-11-16
DE60320095D1 (de)	2008-05-15
US20100028313A1 (en)	2010-02-04
US20050201996A1 (en)	2005-09-15
EP1482959A1 (de)	2004-12-08
EP1482959B1 (de)	2008-04-02
EP1482959A4 (de)	2005-08-03
JP2005525339A (ja)	2005-08-25
AUPS057102A0 (en)	2002-03-07
CN1642563A (zh)	2005-07-20
WO2003068250A1 (en)	2003-08-21

Publication	Publication Date	Title
ATE390928T1 (de)	2008-04-15	Zusammensetzungen zur behandlung von hauterkrankungen
TNSN07208A1 (en)	2008-11-21	3,5-DISUBTITUTED AND 3,5,7-TRISUBSTITUTED-3H-OXAZOLO AND 3H-THIAZOLO [4,5-d] PYRIMIDIN-2-ONE COMPOUNDS AND PRODRUGS THEREOF
DE60236413D1 (de)	2010-07-01	Inhibitoren von hmgb1 zur behandlung von gewebekrankheiten
ATE450269T1 (de)	2009-12-15	Peptid pyyä3-36ü zur behandlung von stoffwechselkrankheiten
TNSN06403A1 (en)	2008-02-22	3-B-D-RIBOFURANOSYLTHIAZOLO[4,5-d]PYRIDIMINE NUCLEOSIDES AND USES THEREOF
MXPA04004966A (es)	2006-03-21	Nucleosidos de 3-beta-d-ribofuranoziltiazol(4,5-d(pirimidina y uso de los mismos.
ATE355374T1 (de)	2006-03-15	Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen
DE502005010615D1 (de)	2011-01-13	Mittel zur behandlung von entzündlichen erkrankungen
AU5584901A (en)	2001-10-30	Use of cyclic gmp-specific phosphodiesterase inhibitors for treatment of parkinson's disease
NO20050851L (no)	2005-03-29	Kaspase-inhibitorer og anvendelser derav
TW200800976A (en)	2008-01-01	New compounds for the treatment of neurological, psychiatric or pain disorders
DE60227658D1 (de)	2008-08-28	Verfahren zur behandlung neurodegenerativer, psychiatrischer und anderer störungen mit deacetylaseinhibitoren
ATE388708T1 (de)	2008-03-15	Piperazinderivate und anwendungsverfahren
ATE554169T1 (de)	2012-05-15	Smad7-inhibitoren zur behandlung von krankheiten des zns
DE50109156D1 (de)	2006-05-04	Mittel zur behandlung von erkrankungen des tracheo-bronchialtraktes, insbesondere der copd
ITMI20030573A1 (it)	2004-09-25	Composti ad azione nootropica, loro preparazione,
MY139368A (en)	2009-09-30	Novel cyclohexyl sulphones
MXPA05008561A (es)	2005-11-04	Uso de esteroides para tratar personas que sufren de trastornos oculares.
IS5101A (is)	1999-06-30	Aðferðir við inngjöf efnasambanda sem eru mótefnigegn CD40L í sambandi við læknismeðferð
ATE508749T1 (de)	2011-05-15	Antidepressiva zur prophylaxe und therapie von zystischer fibrose
ATE494903T1 (de)	2011-01-15	Verwendung von slurp-1 zur behandlung von krankheiten, die durch störungen der acetylcholinerezeptoren ausgelöst werden
ATE458495T1 (de)	2010-03-15	Therapeutische zubereitung für autoimmune erkrankungen
ATE536874T1 (de)	2011-12-15	Dreifache monoamin-wiederaufnahmehemmer zur behandlung von chronischen schmerzen
ATE498397T1 (de)	2011-03-15	Verwendung von isorhamnetin zur behandlung von depressiven verstimmungen und erkrankungen
ATE449607T1 (de)	2009-12-15	Arsentherapie zur behandlung von autoimmunerkrankungen

Legal Events

Date	Code	Title	Description
2008-10-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties